Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and efficacy of adding AZARGA® as a
single agent to prostaglandin monotherapy in patients with either ocular hypertension or
primary open-angle glaucoma.